You can buy or sell APLS and other stocks, options, and ETFs commission-free!
Apellis Pharmaceuticals, Inc. Common Stock, also called Apellis Pharmaceuticals, is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA. The listed name for APLS is Apellis Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
$0.93 per share